Lysophosphatidic acid receptor 6 regulated by miR-27a-3p attenuates tumor proliferation in breast cancer

PURPOSE: Lysophosphatidic acid (LPA) is a bioactive molecule which participates in many physical and pathological processes. Although LPA receptor 6 (LPAR6), the last identified LPA receptor, has been reported to have diverse effects in multiple cancers, including breast cancer, its effects and func...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, J., Guo, S., Li, K., Tian, J., Zong, B., Ai, T., Peng, Y., Zhang, Y., Liu, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885522/
https://www.ncbi.nlm.nih.gov/pubmed/34510318
http://dx.doi.org/10.1007/s12094-021-02704-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885522/
https://www.ncbi.nlm.nih.gov/pubmed/34510318
http://dx.doi.org/10.1007/s12094-021-02704-8

Ejemplares similares